116 related articles for article (PubMed ID: 17216628)
21. Conflict of interest and evaluation research: should we do effectiveness studies of our own educational programs?
Olson CA
J Contin Educ Health Prof; 2013; 33(4):203-5. PubMed ID: 24347098
[No Abstract] [Full Text] [Related]
22. No unfairness in funding of Croatian minister's project.
Risović S
Nature; 2006 Feb; 439(7077):660. PubMed ID: 16467816
[No Abstract] [Full Text] [Related]
23. Toxaphene.
National Toxicology Program
Rep Carcinog; 2011; 12():418-20. PubMed ID: 21863113
[No Abstract] [Full Text] [Related]
24. Medical integrity up in smoke? Conflicts of interest and the lung cancer screening controversy.
Moy B
Oncologist; 2008 May; 13(5):474-6. PubMed ID: 18515732
[No Abstract] [Full Text] [Related]
25. Attitudes toward research participation and investigator conflicts of interest among advanced cancer patients participating in early phase clinical trials.
Gray SW; Hlubocky FJ; Ratain MJ; Daugherty CK
J Clin Oncol; 2007 Aug; 25(23):3488-94. PubMed ID: 17687154
[TBL] [Abstract][Full Text] [Related]
26. Unfortunate oversight.
Nature; 2012 Aug; 488(7409):5. PubMed ID: 22859165
[No Abstract] [Full Text] [Related]
27. Frequency, nature, effects, and correlates of conflicts of interest in published clinical cancer research.
Jagsi R; Sheets N; Jankovic A; Motomura AR; Amarnath S; Ubel PA
Cancer; 2009 Jun; 115(12):2783-91. PubMed ID: 19434666
[TBL] [Abstract][Full Text] [Related]
28. [Uniform format for disclosure of competing interests in the International Committee of Medical Journal Editors journals].
International Committee of Medical Journal Editors
Ugeskr Laeger; 2009 Oct; 171(43):3065-6. PubMed ID: 19852890
[No Abstract] [Full Text] [Related]
29. On the chromium reanalysis.
Paustenbach DJ
Epidemiology; 2009 Jul; 20(4):625-6; author reply 626-7. PubMed ID: 19525695
[No Abstract] [Full Text] [Related]
30. Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology.
Riechelmann RP; Wang L; O'Carroll A; Krzyzanowska MK
J Clin Oncol; 2007 Oct; 25(29):4642-7. PubMed ID: 17925561
[TBL] [Abstract][Full Text] [Related]
31. Chlorinated hydrocarbons and cancer: epidemiologic aspects.
Axelson O
J Toxicol Environ Health; 1980; 6(5-6):1245-51. PubMed ID: 7463516
[TBL] [Abstract][Full Text] [Related]
32. Small study on industry trial sponsorship leads to big questions about quality and bias.
Twombly R
J Natl Cancer Inst; 2007 Jul; 99(13):988-90. PubMed ID: 17596566
[No Abstract] [Full Text] [Related]
33. Perspectives of clinical research coordinators on disclosing financial conflicts of interest to potential research participants.
Friedman JY; Sugarman J; Dhillon JK; Depuy V; Pierre CK; Dinan MA; Allsbrook JS; Schulman KA; Weinfurt KP
Clin Trials; 2007; 4(3):272-8. PubMed ID: 17715256
[TBL] [Abstract][Full Text] [Related]
34. Trust, but verify.
Nature; 2009 Sep; 461(7262):315. PubMed ID: 19759574
[No Abstract] [Full Text] [Related]
35. Re: False-positive results in cancer epidemiology: a plea for epistemological modesty.
Clapp RW; Kriebel D
J Natl Cancer Inst; 2009 Feb; 101(3):211-2; author reply 213-4. PubMed ID: 19176465
[No Abstract] [Full Text] [Related]
36. Scripts for science: a new wrinkle on academic ties with industry.
Hauser SL; Johnston SC
Ann Neurol; 2008 Oct; 64(4):A13-5. PubMed ID: 18991356
[No Abstract] [Full Text] [Related]
37. Industry-sponsored research.
Okike K; Kocher MS; Mehlman CT; Bhandari M
Injury; 2008 Jun; 39(6):666-80. PubMed ID: 18508054
[TBL] [Abstract][Full Text] [Related]
38. Institutes in pharma cash probe.
Ledford H
Nature; 2008 Jun; 453(7198):963. PubMed ID: 18563109
[No Abstract] [Full Text] [Related]
39. Bias in the design, interpretation, and publication of industry-sponsored clinical research.
Hammerschmidt D
Minn Med; 2008 Jun; 91(6):46-7. PubMed ID: 18616022
[No Abstract] [Full Text] [Related]
40. Chlorinated paraffins (C12, 60% chlorine).
National Toxicology Program
Rep Carcinog; 2002; 10():51-2. PubMed ID: 15318387
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
